Bacteraemia caused by beta-haemolytic streptococci in North Queensland: Changing trends over a 14-year period

Clinical Microbiology and Infection

Volumn 17, Issue 8, 2011, Pages 1216-1222

  Harris, P ^a   Siew, D A ^a   Proud, M ^a   Buettner, P ^b   Norton, R ^a  

^a TOWNSVILLE HOSPITAL   (Australia)

^b JAMES COOK UNIVERSITY   (Australia)

Author keywords

Australia; Bacteraemia; Indigenous; North Queensland; haemolytic streptococci

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; BACTEREMIA; BACTERIUM COLONY; BACTERIUM ISOLATION; BETA HEMOLYTIC STREPTOCOCCUS; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS GROUP C;

STREPTOCOCCUS SP. 'GROUP A'; STREPTOCOCCUS SP. 'GROUP B'; STREPTOCOCCUS SP. 'GROUP C';

EID: 79960661199     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03427.x     Document Type: Article

References (36)

1. Efstratiou A. Group A streptococci in the 1990s. J Antimicrob Chemother 2000; 45 (suppl): 3-12.
2. Norton R, Smith HV, Wood N, Siegbrecht E, Ross A, Ketheesan N. Invasive group A streptococcal disease in North Queensland (1996-2001). Indian J Med Res 2004; 119 (suppl): 148-151.
3. O'Grady KA, Kelpie L, Andrews RM et al. The epidemiology of invasive group A streptococcal disease in Victoria, Australia. Med J Aust 2007; 186: 565-569.
4. Carapetis JR, Walker AM, Hibble M, Sriprakash KS, Currie BJ. Clinical and epidemiological features of group A streptococcal bacteraemia in a region with hyperendemic superficial streptococcal infection. Epidemiol Infect 1999; 122: 59-65.
5. Schwartz B, Facklam RR, Breiman RF. Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990; 336: 1167-1171.
6. Kiska DL, Thiede B, Caracciolo J et al. Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis 1997; 176: 992-1000.
7. Carapetis J, Robins-Browne R, Martin D, Shelby-James T, Hogg G. Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone. Clin Infect Dis 1995; 21: 1220-1227.
8. Le Hello S, Doloy A, Baumann F et al. Clinical and microbial characteristics of invasive Streptococcus pyogenes disease in New Caledonia, a region in Oceania with a high incidence of acute rheumatic fever. J Clin Microbiol 2010; 48: 526-530.
9. Steer AC, Magor G, Jenney AW et al. emm and C-repeat region molecular typing of beta-hemolytic Streptococci in a tropical country: implications for vaccine development. J Clin Microbiol 2009; 47: 2502-2509.
10. Davies HD, McGeer A, Schwartz B et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 1996; 335: 547-554.
11. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA 1993; 269: 384-389.
12. O'Brien KL, Beall B, Barrett NL et al. Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin Infect Dis 2002; 35: 268-276.
13. Zurawski CA, Bardsley M, Beall B et al. Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment. Clin Infect Dis 1998; 27: 150-157.
14. Lamagni TL, Darenberg J, Luca-Harari B et al. Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 2008; 46: 2359-2367.
15. Farley MM, Harvey RC, Stull T et al. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med 1993; 328: 1807-1811.
16. Sylvetsky N, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM. Bacteremia due to beta-hemolytic Streptococcus group G: increasing incidence and clinical characteristics of patients. Am J Med 2002; 112: 622-626.
17. Barnham MR, Weightman NC. Changing incidence of detected streptococcal bacteraemia in North Yorkshire, England. Indian J Med Res 2004; 119 (suppl): 160-163.
18. Schuchat A. Group B streptococcus. Lancet 1999; 353: 51-56.
19. Edwards MS, Baker CJ. Group B streptococcal infections in elderly adults. Clin Infect Dis 2005; 41: 839-847.
20. Jackson LA, Hilsdon R, Farley MM et al. Risk factors for group B streptococcal disease in adults. Ann Intern Med 1995; 123: 415-420.
21. Domingo P, Barquet N, Alvarez M, Coll P, Nava J, Garau J. Group B streptococcal meningitis in adults: report of twelve cases and review. Clin Infect Dis 1997; 25: 1180-1187.
22. Colford JM Jr, Mohle-Boetani J, Vosti KL. Group B streptococcal bacteremia in adults. Five years' experience and a review of the literature. Medicine (Baltimore) 1995; 74: 176-190.
23. Skoff TH, Farley MM, Petit S et al. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis 2009; 49: 85-92.
24. Phares CR, Lynfield R, Farley MM et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008; 299: 2056-2065.
25. Carmeli Y, Ruoff KL. Report of cases of and taxonomic considerations for large-colony-forming Lancefield group C streptococcal bacteremia. J Clin Microbiol 1995; 33: 2114-2117.
26. Lopardo HA, Vidal P, Sparo M et al. Six-month multicenter study on invasive infections due to Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis in Argentina. J Clin Microbiol 2005; 43: 802-807.
27. Brandt CM, Spellerberg B. Human infections due to Streptococcus dysgalactiae subspecies equisimilis. Clin Infect Dis 2009; 49: 766-772.
28. Broyles LN, Van Beneden C, Beall B et al. Population-based study of invasive disease due to beta-hemolytic streptococci of groups other than A and B. Clin Infect Dis 2009; 48: 706-712.
29. McDonald MI, Towers RJ, Andrews RM, Benger N, Currie BJ, Carapetis JR. Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. Clin Infect Dis 2006; 43: 683-689.
30. McDonald M, Towers RJ, Andrews RM, Carapetis JR, Currie BJ. Epidemiology of Streptococcus dysgalactiae subsp. equisimilis in tropical communities, Northern Australia. Emerg Infect Dis 2007; 13: 1694-1700.
31. Haidan A, Talay SR, Rohde M, Sriprakash KS, Currie BJ, Chhatwal GS. Pharyngeal carriage of group C and group G streptococci and acute rheumatic fever in an Aboriginal population. Lancet 2000; 356: 1167-1169.
32. Australian Bureau of Statistics. 2010. Available at: (last accessed 30 March 2010).
33. Rantala S, Vuopio-Varkila J, Vuento R, Huhtala H, Syrjanen J. Clinical presentations and epidemiology of beta-haemolytic streptococcal bacteraemia: a population-based study. Clin Microbiol Infect 2009; 15: 286-288.
34. Farley MM. Group B streptococcal disease in nonpregnant adults. Clin Infect Dis 2001; 33: 556-561.
35. Zhao Y, Dempsey K. Causes of inequality in life expectancy between Indigenous and non-Indigenous people in the Northern Territory, 1981-2000: a decomposition analysis. Med J Aust 2006; 184: 490-494.
36. Australian Institute of Health and Welfare. Indigenous mortality data. 2006. Available at: (last accessed 27 April 2010).